Forbes India Cover Story # 254: The race to make a covid 19 vaccine in India

It typically takes five years and about Rs 15 crore for just the first of many phases to introduce a viable vaccine to market. Companies across India such as Zydus Cadila, Serum Institute and Bharat Biotech are working against the clock to shrink this period down to a few months. In this episode Forbes Indias Divya Shekhar takes a deep dive into what this rush looks like on the ground and gives us a glimpse into the path ahead. Podcast produced in association with theindicast.com

You can listen to Forbes India Cover Story # 254: The race to make a covid 19 vaccine in India online on Radio and Podcast. Open the player on this page to stream the available audio.

Forbes India Cover Story # 254: The race to make a covid 19 vaccine in India is an episode from Inside Forbes India by Forbes India Magazine and Indicast Podcast Network.

This episode is 10:34 long.

This episode was published on Jul 11, 2020.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Inside Forbes India when more episodes are available from the podcast feed.